Knight Therapeutics Inc
TSX:GUD
Knight Therapeutics Inc
Operating Income
Knight Therapeutics Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Operating Income
CA$6.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Bausch Health Companies Inc
TSX:BHC
|
Operating Income
$1.6B
|
CAGR 3-Years
7%
|
CAGR 5-Years
26%
|
CAGR 10-Years
6%
|
|
Canopy Growth Corp
TSX:WEED
|
Operating Income
-CA$337.4m
|
CAGR 3-Years
25%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Cronos Group Inc
TSX:CRON
|
Operating Income
-$79.9m
|
CAGR 3-Years
22%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Operating Income
$12.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
T
|
Terrascend Corp
CNSX:TER
|
Operating Income
-$23.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Knight Therapeutics Inc's Operating Income?
Operating Income
6.4m
CAD
Based on the financial report for Dec 31, 2023, Knight Therapeutics Inc's Operating Income amounts to 6.4m CAD.